Thabor Therapeutics
Biotechnology Research
Develops innovative treatments for mucosal inflammatory diseases
About us
Thabor's website
- Website
-
www.thabor-tx.com
External link for Thabor Therapeutics
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Type
- Privately Held
Employees at Thabor Therapeutics
-
Marina Guillet
Chief Executive Officer chez SAMABRIVA 🌿💊 Bioproduction of APIs
-
Séverine Ciré
Immunologist, Medical and scientific project manager with some experience in medical copywriting
-
Xavier Treton
Professor of Gastroenterology (MD, PhD), Paris Inflammatory Bowel Disease (IBD) Center, Centre Ambroise Pare-Hartmann, Neuilly, France
-
Kamel Bachiri, PhD
PhD in molecular and cellular biology